About Allogene (ALLO)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more
- USD1.05
- USD1.08
- USD0.99
- USD3.78
- -18.70%
- --
- 6.30M
- 4.70M
- 227M
- 0.86
- -55.70%
Stock News
2 hours ago
Consumers are losing patience with $17 salads. Have we reached peak ‘slop bowl’?
MarketWatch
3 hours ago
Apple Watch getting redesigned blood oxygen feature following legal dispute
CNBC
4 hours ago
Ulta and Target will end deal for in-store beauty shops next year
CNBC
4 hours ago
Is Oceaneering International, Inc. (NYSE:OII) Trading At A 42% Discount?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
